New Product Applications: Introducing the Cirrus 6000
-
By
-
Karen Appold, contributing writer
-
March 1, 2025
-
5 min
By
Karen Appold, contributing writer
March 1, 2025
by Karen Appold, contributing writer
March 1, 2025
by Aimin Sun, Siying Li, Yu Cao, Bohao Wang, Muzi Li, Jinfeng Qu
May 13, 2026
Phase 1 nonrandomized trial reported no drug-related serious adverse events, but efficacy remains unproven
by Kerri Miller
May 7, 2026